MedTrace Logo

Clinical Impact of 16S rDNA PCR

NCT03915275 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-04-16

No results posted yet for this study

Summary

The main objective of this study is to evaluate the impact of a positive 16S rDNA PCR in various sites on patient's management.

The secondary objectives of the protocol are:

* to evaluate bacterial identification performance
* to evaluate the effect of previous antibiotic therapy
* to analyze the management of discordant results between 16S PCR and culture identification

Conditions

Sponsors & Collaborators

  • University Hospital, Strasbourg, France

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03915275 on ClinicalTrials.gov